AR002946A1 - A SET FOR USE IN THE TREATMENT OR PREVENTION OF OSTEOPOROSIS IN MAMMALS ACCORDING TO A CYCLIC DIET. - Google Patents
A SET FOR USE IN THE TREATMENT OR PREVENTION OF OSTEOPOROSIS IN MAMMALS ACCORDING TO A CYCLIC DIET.Info
- Publication number
- AR002946A1 AR002946A1 ARP950100438A AR10043895A AR002946A1 AR 002946 A1 AR002946 A1 AR 002946A1 AR P950100438 A ARP950100438 A AR P950100438A AR 10043895 A AR10043895 A AR 10043895A AR 002946 A1 AR002946 A1 AR 002946A1
- Authority
- AR
- Argentina
- Prior art keywords
- osteoporosis
- prevention
- treatment
- diet
- cyclic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La invención se refiere a un conjunto para uso en un ciclo terapéutico el cual se basa en la administración secuencial de ácido tiludrónico o de una saly/o solvato del mismo y de calcio durante 28 a 31 días, para el tratamiento y/o la prevención de la osteoporosis. Dicho conjunto contiene: (a) 7 dosis deácido tiludrónico o de una sal aceptable farmacéuticamente y/o un solvato del mismo y (b) un suplemento nutritivo dividido en dosis que se administrarándurante los 21 a 24 días posteriores a (a).The invention relates to a set for use in a therapeutic cycle which is based on the sequential administration of tiludronic acid or a salt and / or solvate thereof and calcium for 28 to 31 days, for the treatment and / or prevention of osteoporosis. Said set contains: (a) 7 doses of tiludronic acid or a pharmaceutically acceptable salt and / or a solvate thereof and (b) a nutritional supplement divided into doses to be administered during the 21 to 24 days after (a).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9414630A FR2727629A1 (en) | 1994-12-06 | 1994-12-06 | OSTEOPOROSIS TREATMENT CYCLE KIT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR002946A1 true AR002946A1 (en) | 1998-05-27 |
Family
ID=9469504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP950100438A AR002946A1 (en) | 1994-12-06 | 1995-12-05 | A SET FOR USE IN THE TREATMENT OR PREVENTION OF OSTEOPOROSIS IN MAMMALS ACCORDING TO A CYCLIC DIET. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0797444A1 (en) |
| JP (1) | JPH10509729A (en) |
| KR (1) | KR980700083A (en) |
| CN (1) | CN1168634A (en) |
| AR (1) | AR002946A1 (en) |
| AU (1) | AU4307396A (en) |
| BR (1) | BR9509961A (en) |
| CA (1) | CA2207028A1 (en) |
| CZ (1) | CZ175397A3 (en) |
| FI (1) | FI972383A (en) |
| FR (1) | FR2727629A1 (en) |
| HU (1) | HUT77382A (en) |
| IL (1) | IL116168A0 (en) |
| MA (1) | MA23737A1 (en) |
| NO (1) | NO972558L (en) |
| PL (1) | PL320564A1 (en) |
| SK (1) | SK68597A3 (en) |
| TR (1) | TR199501530A1 (en) |
| WO (1) | WO1996017616A1 (en) |
| ZA (1) | ZA9510184B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5994329A (en) | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
| US6432932B1 (en) | 1997-07-22 | 2002-08-13 | Merck & Co., Inc. | Method for inhibiting bone resorption |
| RU2387451C2 (en) | 2002-05-10 | 2010-04-27 | Ф.Хоффманн-Ля Рош Аг | Bisphosphonic acids intended for treatment and prevention of osteoporosis |
| PT1596870E (en) * | 2002-12-20 | 2007-10-15 | Hoffmann La Roche | High dose ibandronate formulation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE114473T1 (en) * | 1984-04-30 | 1994-12-15 | Procter & Gamble | EQUIPMENT FOR USE IN THE TREATMENT OF OSTEOPOROSIS. |
| US4761406A (en) * | 1985-06-06 | 1988-08-02 | The Procter & Gamble Company | Regimen for treating osteoporosis |
| CA2138367C (en) * | 1992-06-30 | 1998-09-22 | Marion David Francis | Use of phosphonates for the treatment of osteoporosis |
| FR2694558B1 (en) * | 1992-08-05 | 1994-10-28 | Sanofi Elf | Monohydrate of the disodium salt of 4-chlorophenylthiomethylene bisphosphonic acid, its preparation, the pharmaceutical compositions containing it. |
-
1994
- 1994-12-06 FR FR9414630A patent/FR2727629A1/en active Granted
-
1995
- 1995-11-28 IL IL11616895A patent/IL116168A0/en unknown
- 1995-11-30 ZA ZA9510184A patent/ZA9510184B/en unknown
- 1995-12-04 MA MA24086A patent/MA23737A1/en unknown
- 1995-12-04 TR TR95/01530A patent/TR199501530A1/en unknown
- 1995-12-05 EP EP95941761A patent/EP0797444A1/en not_active Withdrawn
- 1995-12-05 CN CN95196670A patent/CN1168634A/en active Pending
- 1995-12-05 KR KR1019970703784A patent/KR980700083A/en not_active Application Discontinuation
- 1995-12-05 SK SK685-97A patent/SK68597A3/en unknown
- 1995-12-05 AR ARP950100438A patent/AR002946A1/en unknown
- 1995-12-05 WO PCT/FR1995/001596 patent/WO1996017616A1/en not_active Application Discontinuation
- 1995-12-05 JP JP8517359A patent/JPH10509729A/en not_active Ceased
- 1995-12-05 PL PL95320564A patent/PL320564A1/en unknown
- 1995-12-05 AU AU43073/96A patent/AU4307396A/en not_active Abandoned
- 1995-12-05 CA CA002207028A patent/CA2207028A1/en not_active Abandoned
- 1995-12-05 CZ CZ971753A patent/CZ175397A3/en unknown
- 1995-12-05 HU HU9702097A patent/HUT77382A/en unknown
- 1995-12-05 BR BR9509961A patent/BR9509961A/en not_active Application Discontinuation
-
1997
- 1997-06-05 NO NO972558A patent/NO972558L/en unknown
- 1997-06-05 FI FI972383A patent/FI972383A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0797444A1 (en) | 1997-10-01 |
| FI972383A0 (en) | 1997-06-05 |
| BR9509961A (en) | 1997-11-25 |
| HUT77382A (en) | 1998-04-28 |
| SK68597A3 (en) | 1997-11-05 |
| NO972558L (en) | 1997-08-05 |
| MX9704105A (en) | 1997-09-30 |
| IL116168A0 (en) | 1996-01-31 |
| NO972558D0 (en) | 1997-06-05 |
| PL320564A1 (en) | 1997-10-13 |
| AU4307396A (en) | 1996-06-26 |
| CN1168634A (en) | 1997-12-24 |
| FR2727629A1 (en) | 1996-06-07 |
| KR980700083A (en) | 1998-03-30 |
| JPH10509729A (en) | 1998-09-22 |
| FR2727629B1 (en) | 1997-02-28 |
| ZA9510184B (en) | 1996-06-11 |
| CZ175397A3 (en) | 1997-10-15 |
| WO1996017616A1 (en) | 1996-06-13 |
| MA23737A1 (en) | 1996-07-01 |
| CA2207028A1 (en) | 1996-06-13 |
| FI972383A (en) | 1997-06-05 |
| TR199501530A1 (en) | 1996-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0600079T3 (en) | Oral 1alpha-hydroxypravitamin D | |
| ES2040232T3 (en) | MEDICINAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING A SINGLE DOSE OF 10 TO 240 MG OF DIHIDROPIRIDINA. | |
| ES2172510T3 (en) | NEW COMBINATION OF FORMOTEROL AND BUDESONIDA. | |
| AR042262A2 (en) | USE OF 8,9-DIHYDROESTRONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ATEROSCLEROSIS | |
| ES2162615T3 (en) | METHOD TO TREAT OR PREVENT TYPE 1 DIABETES THROUGH ORAL INSULIN ADMINISTRATION. | |
| CR6458A (en) | VALDECOXIB COMPOSITIONS | |
| ES2188782T3 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING DARIFENACINE. | |
| FI940787A0 (en) | Dosage form for short-term administration of the drug | |
| AR020803A1 (en) | A COMPOSITION THAT INCLUDES FEXOFENADINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINE | |
| ATE189400T1 (en) | BONE GROWTH-PROMOTING COMPOSITION | |
| GR1000419B (en) | Dosage form for acalcium antagonist supply | |
| AR035946A1 (en) | PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES | |
| AR002946A1 (en) | A SET FOR USE IN THE TREATMENT OR PREVENTION OF OSTEOPOROSIS IN MAMMALS ACCORDING TO A CYCLIC DIET. | |
| DE3875611T2 (en) | PHARMACEUTICAL COMPOSITIONS. | |
| ES2042831T3 (en) | PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS. | |
| ATE123416T1 (en) | ORALLY ADMINISTERED PHARMACEUTICAL PRODUCT, IN PARTICULAR FOR IRON AND MAGNESIUM SUBSTITUTION THERAPY. | |
| KR830008678A (en) | Analgesic composition | |
| KR890001558A (en) | Zephyron and its pharmaceutically acceptable acid addition salts alleviate panic disorder | |
| SE8304818L (en) | MEDICINE WITH ANTICULAR, SPASMOLYTIC AND LOCAL ANESTIC EFFECTS | |
| JPS6438027A (en) | Remedy for cancer | |
| MD1588F1 (en) | Method of burn shock treatment | |
| UA15281A (en) | Method for treatment of chronic coronary heart disease |